Lexaria Bioscience Corp. (NASDAQ: LEXX): A Review of Its Research Developments
Lexaria Bioscience, the global innovator behind DehydraTECH drug delivery technology, has continuously focused on research into its patented technology The…
Lexaria Bioscience, the global innovator behind DehydraTECH drug delivery technology, has continuously focused on research into its patented technology The…
There is an urgent need for large-scale biosynthetic processing that preserves the purity and consistency of cannabinoids Acquired by InMed…
In 2021, Mydecine made significant progress in creating and commercializing new treatments for mental health and addiction disorders It also…
The company exhibited at the premier event, held March 31–April 1, 2022 ACT has worked to strengthen its presence in…
NEI reports strong bipartisan support for nuclear energy throughout the 117th Congress Hallmark pieces of legislation have demonstrated that carbon-free,…
Flora Growth Corp. (NASDAQ: FLGC) recently announced the successful import of Mambe CBD-containing food and beverage products into the United…
Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies committed to enhancing U.S. security operations, has promoted four employees…
Correlate Infrastructure Partners (OTCQB: CIPI) today announced completion of the company’s corporate name change from Triccar Inc. to Correlate Infrastructure…
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has entered agreements with Altria Client Services LLC. According to…
Friendable (OTC: FDBL) today released a new corporate presentation and 2022 strategy and announced additional increases in certain key metrics…